INMD

Rating neutralAI Memo

InMode

As of 2026-10-10/Confidence low

Open ticker Back to Memos

Data freshness

AI Memo

As of 2026-10-10 • Model: RankAlpha Sentiment Codex

Decision Panel

Action, confidence, horizon, and decision blockers at a glance.

Action

neutral

Confidence

low

Horizon

—

Key catalyst

Clarification of the acquisition proposals • 2026-12-31

Base target: $15 / p=45% prob

Biggest risk

No transaction agreement was announced in the committee statement. Q2 GAAP operating margin fell to 13% from 24%, and management expected cost and mix pressures to continue. Failure of a deal or continued margin erosion could outweigh the apparent bid discount. [#SEC-6K-2026-07-20] Committee statement [#PR-EARNINGS-2026-08-05] Company results

Invalidation

Break below $11 or thesis failure.

What would change my mind?

The $14.21 October 9 anchor is below Steel's stated $16.75 offer, and InMode's $501.1 million June 30 cash position plus growing consumables and service revenue offer support if a transaction progresses or operating margins stabilize. A completed transaction is not assumed. [#PR-EARNINGS-2026-08-05] Company results

Research note

Recommendation

neutral

Confidence

low

As of

2026-10-10

Base target

$15

p=45%

Bull target

$17

p=30%

Bear target

$11

p=25%

Key bullets

Fast scan of bull, bear, and watch items

BullKey bullets

Delivery against 2026 revenue and margin outlook
Morpheus8 Cool commercial uptake
The $14.21 October 9 anchor is below Steel's stated $16.75 offer, and InMode's $501.1 million June 30 cash position plus growing consumables and service revenue offer support if a transaction progresses or operating margins stabilize.

BearKey bullets

Flat Q2 revenue and no disclosed Morpheus8 Cool sales contribution leave the growth outlook uncertain.
Q2 gross and operating margins declined year over year; management cited cost of goods sold, product mix, sales-team restructuring, investment, and professional-services costs, and expected these pressures to continue.
[#PR-EARNINGS-2026-08-05] Company results

WatchKey bullets

Clarification of the acquisition proposals

Summary

High-level snapshot

Recommendation

neutral

Model confidence

low

Timeframe

Asset

Equity

Trigger

Base case: $15 (p=45%)

Target spread vs base: +16% / -23%

Scenario probabilities

Bull Target: $17 (p=30%)Base Target: $15 (p=45%)Bear Target: $11 (p=25%)

Commentary

Cautious monitoring view. The packet supplies no measured news, social, options, short-interest, or employee sentiment; zero entries are missing-data placeholders, not neutral readings. It also supplies no verified post-earnings price reaction or dated analyst revisions. The deterministic prior is positive, but evidence quality is 0.16, uncertainty is 0.862, and thesis-change intensity is only 0.06.

As of 2026-10-10 • Updated bi-weekly / post-earningsSource: Internal modelMethodology

Analyst Summary

Thesis highlights from the latest analysis

Bull Case

Bear Case

Drivers

Scannable catalysts and supporting factors

Delivery against 2026 revenue and margin outlook
Morpheus8 Cool commercial uptake

Scenarios

Bull Target (Scenario probability)

$17 / p=30% prob

Base Target (Scenario probability)

$15 / p=45% prob

Bear Target (Scenario probability)

$11 / p=25% prob

Analysis 2026-10-10 · RankAlpha Sentiment Codex

Analysis reference price unavailable. Targets are shown without scenario returns.

Sentiment & Exposure

News Sentiment (30d)

0.00

Social Sentiment (7d)

0.00

Events

Other notable items detected

EVENT2026-12-31
Clarification of the acquisition proposals
In July, InMode's independent committee said it was evaluating a CEO-linked proposal and a Steel Partners proposal to acquire the entire company, but had made no recommendation or agreement. Steel's stated offer was $16.75 per share. A committee decision could materially move the stock; the current validity of either proposal and the timing of any decision remain unverified. The date is a monitoring horizon, not a company deadline. [#SEC-6K-2026-07-20] Committee statement Steel proposal
Prob 40.00% • Move 18.00% • Priced-in 45.00%

Short-term Catalysts

Next few weeks

Delivery against 2026 revenue and margin outlook
2026-12-31
Q2 revenue was flat year over year at $95.6 million, while GAAP gross margin fell to 75% from 80%. Consumables and service revenue rose 13%. Management projected full-year revenue of $365 million–$375 million and non-GAAP gross margin of 74%–76%, but said cost and mix pressures could persist. Subsequent results will test whether stabilization offsets those pressures. The date is a monitoring horizon. [#PR-EARNINGS-2026-08-05] Company release filed with the SEC
Prob 50% • Move 8% • Priced-in 55%

Long-term Catalysts

Months to a year

Morpheus8 Cool commercial uptake
2027-03-31
InMode listed the September launch of Morpheus8 Cool on its investor-relations site. The available announcement does not establish orders or revenue contribution; measurable uptake would be needed to support a growth thesis. The date is a monitoring horizon. [#PR-2026-09-09] Company investor-relations releases
Prob 35% • Move 7% • Priced-in 30%

Risks

Flat Q2 revenue and no disclosed Morpheus8 Cool sales contribution leave the growth outlook uncertain.
Q2 gross and operating margins declined year over year; management cited cost of goods sold, product mix, sales-team restructuring, investment, and professional-services costs, and expected these pressures to continue. [#PR-EARNINGS-2026-08-05] Company results
The committee reported no recommendation, agreement, or assured timetable; the current status of the competing proposals is unverified. [#SEC-6K-2026-07-20] Committee statement

Peers

Symbol	Summary
BSX	Large-cap medical-device benchmark, not a direct aesthetic-radiofrequency valuation comparable.
EW	Device-sector benchmark; structural-heart exposure makes demand and product comparisons loose.
QDEL	Similar-market-cap health-care-equipment candidate, but diagnostics is not a direct operating comparable.

Sources

Internal and external references used in this analysis

Model source: RankAlpha Sentiment Codex
Analysis date: 2026-10-10

Loading AI feed…

Symbol

Summary

BSX

Large-cap medical-device benchmark, not a direct aesthetic-radiofrequency valuation comparable.

Device-sector benchmark; structural-heart exposure makes demand and product comparisons loose.

QDEL

Similar-market-cap health-care-equipment candidate, but diagnostics is not a direct operating comparable.